Over bitter protests from the pharmaceutical industry, California this month enacted a law that requires drug makers to explain and justify prices for some medicines.

Predictably, those who backed the effort are hailing the move as a significant victory, because they hope this will become the first step toward reining in drug prices.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I’m always perplexed when I hear that drugs should be more affordable to patients. What you’re really saying is they should be more affordable to the insurance companies. Any drug over $50 a month is unaffordable to most Americans, particularly when having 3 to 4 rxs per month. So the list price of all drugs should be no more than $50 per month? If a drug has, say, a $5000 list price, the manfacturer can cut that price by 90% and it is STILL not “affordable”. This is really about the payers and what % of a drug’s cost they will cover. Drugs will never be “affordable”. Just like surgeries and hospital stays are not “affordable”. If this law results in a 50% cut in drug prices (which it won’t), the majority of today’s high priced drugs will still not be affordable, at least not until payers start paying for them in a way that minimizes cost sharing to an affordable price for the patient.

  • Ed:

    Yes it is a lab but I rather have a lab rather than nothing. If we shame any other business, politicians and or writer for legitimate reasons they all will eventually pay attention and think before taking a leap of greed.

    A toothless animal can be frightening to person who has never seen an animal. Cheers.

  • Hello Ed. Just a couple thoughts responding to your thoughtful piece. Yes, states can only do so much. But this bill was important because it moves us toward greater transparency on Rx pricing, and allows CA the chance to push back on large price increases. Both are important. The drug corporations would not have pulled out all the stops to beat it if it was not a threat to them. And, longer game includes encouraging phrma to consider meaningful federal reforms to avoid a patchwork of 50 state regs. All moving us in the right direction. Glass way more than half full.

Your daily dose of news in health and medicine

Privacy Policy